⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

October 10, 2015HepatologyOpen Access

Time to Abandon NASH?

View Full Paper

Ask AI

Bookmark

Share

Abstract

1Head of Hepatology, Codirector, University Clinic for Visceral Surgery and Medicine, University of BernInselspitalBernSwitzerland

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jean‐François Dufour (2015) studied this question.

synapsesocial.com/papers/6a205a55497d35c09ae72e3e https://doi.org/10.1002/hep.28276

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Design and validation of a histological scoring system for nonalcoholic fatty liver disease†other · 2005 · 10,761 citations
2Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver diseaseOriginal Research · 2014 · 625 citations
3The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2review · 2015 · 161 citations
4Obesity-Dependent Metabolic Signatures Associated with Nonalcoholic Fatty Liver Disease ProgressionDiagnostic Study · 2012 · 226 citations
5A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkersOriginal Research · 2015 · 75 citations